vs
Side-by-side financial comparison of authID Inc. (AUID) and Dianthus Therapeutics, Inc. (DNTH). Click either name above to swap in a different company.
authID Inc. is the larger business by last-quarter revenue ($406.0K vs $284.0K, roughly 1.4× Dianthus Therapeutics, Inc.). authID Inc. runs the higher net margin — -994.0% vs -22687.3%, a 21693.3% gap on every dollar of revenue. On growth, authID Inc. posted the faster year-over-year revenue change (103.2% vs -78.6%). Over the past eight quarters, authID Inc.'s revenue compounded faster (60.6% CAGR vs -44.6%).
authID Inc. is a global provider of AI-powered biometric authentication and identity verification solutions. It serves enterprise clients across financial services, healthcare, e-commerce and public sectors, helping prevent identity fraud, simplify user onboarding, and strengthen access security for digital and physical scenarios.
Dianthus Therapeutics is a clinical-stage biopharmaceutical firm focused on developing targeted therapies for rare immunological and inflammatory diseases. It advances antibody-based candidates to address unmet needs of severe patients, operating primarily in the U.S. with global development partners.
AUID vs DNTH — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $406.0K | $284.0K |
| Net Profit | $-4.0M | $-64.4M |
| Gross Margin | — | — |
| Operating Margin | -1002.8% | -24486.3% |
| Net Margin | -994.0% | -22687.3% |
| Revenue YoY | 103.2% | -78.6% |
| Net Profit YoY | 12.2% | -126.6% |
| EPS (diluted) | — | $-1.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $406.0K | $284.0K | ||
| Q3 25 | $-106.1K | $396.0K | ||
| Q2 25 | $1.4M | — | ||
| Q1 25 | $296.3K | $1.2M | ||
| Q4 24 | $199.7K | $1.3M | ||
| Q3 24 | $248.9K | $2.2M | ||
| Q2 24 | $280.4K | $1.9M | ||
| Q1 24 | $157.4K | $874.0K |
| Q4 25 | $-4.0M | $-64.4M | ||
| Q3 25 | $-5.2M | $-36.8M | ||
| Q2 25 | $-4.4M | — | ||
| Q1 25 | $-4.3M | $-29.5M | ||
| Q4 24 | $-4.6M | $-28.4M | ||
| Q3 24 | $-3.4M | $-25.2M | ||
| Q2 24 | $-3.3M | $-17.6M | ||
| Q1 24 | $-3.1M | $-13.7M |
| Q4 25 | -1002.8% | -24486.3% | ||
| Q3 25 | 4930.0% | -10173.7% | ||
| Q2 25 | -309.5% | — | ||
| Q1 25 | -1477.9% | -2852.7% | ||
| Q4 24 | -2349.3% | -2406.9% | ||
| Q3 24 | -1411.5% | -1376.6% | ||
| Q2 24 | -1185.6% | -1191.8% | ||
| Q1 24 | -2003.7% | -2041.6% |
| Q4 25 | -994.0% | -22687.3% | ||
| Q3 25 | 4873.8% | -9284.1% | ||
| Q2 25 | -303.5% | — | ||
| Q1 25 | -1464.8% | -2537.5% | ||
| Q4 24 | -2300.1% | -2144.8% | ||
| Q3 24 | -1351.8% | -1159.0% | ||
| Q2 24 | -1162.9% | -945.1% | ||
| Q1 24 | -1942.8% | -1573.0% |
| Q4 25 | — | $-1.53 | ||
| Q3 25 | — | $-0.97 | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-0.82 | ||
| Q4 24 | — | $-0.76 | ||
| Q3 24 | — | $-0.74 | ||
| Q2 24 | — | $-0.51 | ||
| Q1 24 | — | $-0.54 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $404.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $8.6M | $493.4M |
| Total Assets | $10.0M | $530.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $404.3M | ||
| Q3 25 | — | $402.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $263.2M | ||
| Q4 24 | — | $275.2M | ||
| Q3 24 | — | $281.1M | ||
| Q2 24 | — | $360.7M | ||
| Q1 24 | — | $377.0M |
| Q4 25 | $8.6M | $493.4M | ||
| Q3 25 | $8.9M | $546.5M | ||
| Q2 25 | $13.0M | — | ||
| Q1 25 | $7.6M | $328.6M | ||
| Q4 24 | $11.5M | $352.5M | ||
| Q3 24 | $15.6M | $337.9M | ||
| Q2 24 | $18.3M | $358.2M | ||
| Q1 24 | $10.9M | $372.7M |
| Q4 25 | $10.0M | $530.9M | ||
| Q3 25 | $10.7M | $577.4M | ||
| Q2 25 | $15.8M | — | ||
| Q1 25 | $10.0M | $348.6M | ||
| Q4 24 | $14.5M | $374.0M | ||
| Q3 24 | $17.5M | $354.2M | ||
| Q2 24 | $20.2M | $369.0M | ||
| Q1 24 | $12.7M | $382.5M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-3.2M | $-47.0M |
| Free Cash FlowOCF − Capex | — | $-47.1M |
| FCF MarginFCF / Revenue | — | -16591.9% |
| Capex IntensityCapex / Revenue | — | 48.6% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-132.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-3.2M | $-47.0M | ||
| Q3 25 | $-3.4M | $-30.6M | ||
| Q2 25 | $-3.0M | — | ||
| Q1 25 | $-5.4M | $-27.6M | ||
| Q4 24 | $-3.2M | $-27.4M | ||
| Q3 24 | $-2.7M | $-21.3M | ||
| Q2 24 | $-2.8M | $-14.5M | ||
| Q1 24 | $-2.9M | $-14.9M |
| Q4 25 | — | $-47.1M | ||
| Q3 25 | — | $-30.6M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-27.7M | ||
| Q4 24 | — | $-27.5M | ||
| Q3 24 | — | $-21.3M | ||
| Q2 24 | — | $-14.5M | ||
| Q1 24 | — | $-15.0M |
| Q4 25 | — | -16591.9% | ||
| Q3 25 | — | -7717.2% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -2377.8% | ||
| Q4 24 | — | -2072.0% | ||
| Q3 24 | — | -980.3% | ||
| Q2 24 | — | -780.7% | ||
| Q1 24 | — | -1713.2% |
| Q4 25 | — | 48.6% | ||
| Q3 25 | — | 1.3% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 2.1% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 1.2% | ||
| Q2 24 | — | 0.9% | ||
| Q1 24 | — | 3.7% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
